| Literature DB >> 29233959 |
Ravindra P Jumde1, Francesco Lanza1, Tilde Pellegrini1, Syuzanna R Harutyunyan2.
Abstract
General methods to prepare chiral pyridine derivatives are greatly sought after due to their significance in medicinal chemistry. Here, we report highly enantioselective catalytic transformations of poorly reactive β-substituted alkenyl pyridines to access a wide range of alkylated chiral pyridines. The simple methodology involves reactivity enhancement via Lewis acid (LA) activation, the use of readily available and highly reactive Grignard reagents, and a copper-chiral diphosphine ligand catalyst. Apart from allowing the introduction of different linear, branched, cyclic, and functionalised alkyl chains at the β-position of alkenyl pyridines, the catalytic system also shows high functional group tolerance.Entities:
Year: 2017 PMID: 29233959 PMCID: PMC5727103 DOI: 10.1038/s41467-017-01966-7
Source DB: PubMed Journal: Nat Commun ISSN: 2041-1723 Impact factor: 14.919
Fig. 1Enantioselective nucleophilic addition to alkenyl pyridines
Optimisation of reaction conditions
|
| |||||
|---|---|---|---|---|---|
| Entry | Solvent |
| Lewis acid, equiv.b | Conv. (%)c | ee (%)d |
| 1 | DCM |
| BF3⋅Et2O, 1.1 | 0 | — |
| 2 | DCM |
| B[PhF5]3, 1.1 | 0 | — |
| 3 | DCM |
| TMSOTf, 1.5 | 89 | 89 |
| 4 | DCM |
| TMSOTf, 2.0 | 85 | 85 |
| 5 | DCM |
| TMSOTf, 3.0 | 91 | 89 |
| 6 | DCM |
| TMSOTf, 1.5 | 91 | 92 |
| 7 | DCM |
| TMSOTf, 2.0 | 95 | 93 |
| 8 | DCM |
| TMSOTf, 3.0 | 100 | 93 |
| 9 | Et2O |
| TMSOTf, 3.0 | 62 | 95 |
| 10 | MTBE |
| TMSOTf, 3.0 | 67 | 96 |
| 11 | Toluene |
| TMSOTf, 3.0 | 79 | 87 |
| 12 | DCM |
| TMSOTf, 3.0 | 76 | 45 |
| 13 | DCM |
| TMSOTf, 3.0 | 93 | 81 |
| 14 | DCM |
| TMSOTf, 3.0 | 95 | 90 |
a6 or 12 mol% of L was used in combination with 5 or 10 mol% of CuBr·SMe2 respectively
bEquivalents of EtMgBr used correspond to that of the Lewis acid
cDetermined by 1H NMR spectroscopy
dDetermined by chiral HPLC
Substrate scope
|
|
aConditions A: TMSOTf (3 equiv.) and EtMgBr (3 equiv.); conditions B: BF3⋅Et2O (1.5 equiv) and EtMgBr (1.5 equiv.)
bReported yields are for isolated products
cDetermined by chiral HPLC
dThe absolute configurations of products were determined on the basis of single-crystal X-ray diffraction analysis of compound 2a′ (see Supplementary Information)
eEtMgBr diluted in toluene and added dropwise over 2 h
fee of corresponding alcohol 2c' after deprotection
g5 mol% of catalyst used
hee of the corresponding ether 10
iSmall amount of unreacted substrate (≤9%) is not separable from product by chromatography, yields are calculated by purity of product in the mixed fraction by 1H NMR
Grignard scope
|
| |||||
|---|---|---|---|---|---|
| Entry | R′MgX | R | Product | Yield (%)a | ee (%)b |
| 1 | EtMgBr | Ph |
| 94 | 93 |
| 2 | PrMgCl | Ph |
| 75 | 93 |
| 3 | HexMgBr | Ph |
| 81 | 95 |
| 4 |
| Ph |
| 65 | 97 |
| 5 |
| Hexyl |
| 56 | 64 |
| 6c | c-PentMgBr | Hexyl |
| 54 | 89 |
| 7 | CH2=CH(CH2)2MgBr | Hexyl |
| 91 | 93 |
| 8 | CH2=CH(CH2)3MgBr | Ph |
| 66 | 90 |
| 9 | Ph(CH2)2MgBr | Hexyl |
| 89 | 97 |
| 10d | MeMgBr | Hexyl |
| 50 | 93 |
| 11e | PhMgBr | Hexyl |
| 84 | 0 |
aReported yields are for isolated products
bDetermined by chiral HPLC
c4. equiv. of Grignard was used
dReaction was carried out at 0 °C for 5 h
eLigand L10 was used (see Supplementary Table 1 for L10 structure)
Fig. 2Practical aspects of CA to alkenyl pyridines and functionalisation of chiral pyridine products. a Scaling up, raising the reaction temperature, as well as use of recovered Cu-catalyst, are well tolerated by the present catalytic system. b The presence of a reactive substituent on the pyridine ring allowed the addition products to be further functionalised
Fig. 3Cu-catalysed CA to substrates 12 and proposed catalytic cycle. a These experiments clarify the difference in reactivity between 4-substituted and 2-substituted pyridines. b Proposed tentative catalytic cycle for LA promoted Cu-catalysed CA of Grignard reagents to alkenyl pyridines 1a
Effect of different LAs in Cu(I)-catalysed addition of EtMgBr to 1a
|
| ||||||
|---|---|---|---|---|---|---|
| Entry | LA |
| Cu/ | Conv. (%)a | Yield (%)b | ee (%)c |
| 1 | BF3·OEt2 | −78 | 10 | 0 | NA | NA |
| 2 | BF3·OEt2 | −78 | — | 0 | NA | NA |
| 3 | TMSOTf | −78 | 10 | 100 | 94 | 93 |
| 4 | TMSOTf | −78 | — | 100 (in 4 h) | ND | Rac |
| 5 | TMSCl | −78 | — | 0 | NA | NA |
| 6 | TMSBr | −78 | — | 0 | NA | NA |
| 7 | TMSCl | −78 | 10 | 60 | 47 | >99.9 |
| 8 | TMSBr | −78 | 10 | 100 | 73 | >99.9 |
| 9 | TESOTf | −78 | 10 | 95 | 85 | 88 |
| 10 | TBSOTf | −78 | 10 | 87 | 75 | 77 |
| 11 | TBDPSOTf | −78 | 10 | 96 | 47 | 62 |
| 12 | TBDPSOTf | −78 | — | 40 | ND | Rac |
| 13 | TBSCl, TBDPSCl, TBDMSCl | (−78)–0 | 10–25 | 0 | NA | NA |
| 14 | TESCl | 0 | 10 | 40 | ND | 82 |
| 15 | TESCl | 0 | — | 0 | NA | NA |
| 16 | TMSCl | 0 | 10 | 91 | ND | 91 |
aConversion was determined by 1H NMR
bIsolated yields
cDetermined by chiral HPLC